Market Cap 103.47M
Revenue (ttm) 0.00
Net Income (ttm) -26.77M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 638,800
Avg Vol 377,450
Day's Range N/A - N/A
Shares Out 111.74M
Stochastic %K 14%
Beta 1.02
Analysts Strong Sell
Price Target $6.74

Company Profile

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutan...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 289 910 0850
Fax: 905 481 2394
Address:
2265 Upper Middle Road East, Suite 602, Oakville, Canada
Covode13
Covode13 Mar. 21 at 8:24 PM
$CRDL .80’s here we come.
0 · Reply
HeyYio
HeyYio Mar. 21 at 9:36 AM
$CRDL mmcap just got in bro. (The big investment I am referring to). I dont think 4 months have passed yet.
1 · Reply
Rbyild
Rbyild Mar. 20 at 7:01 PM
$CRDL I once heard Cramer say, “stocks stop going down at zero.” 😂 Pretty sure those at MMCAP know this. Currently a tute-bag-holder, that has a ton of shares and has dumped before. What sucks for retail is very few if any other tutes followed them down the rabbit hole this time. How bout them apples?
0 · Reply
Blueshadows
Blueshadows Mar. 20 at 5:58 PM
$CRDL well hopefully this doesn’t tank to much more. Like I said before I’m in till these trials are done just a personal choice and personal risk
1 · Reply
RobbyAxelrod1
RobbyAxelrod1 Mar. 20 at 5:43 PM
$CRDL Competitor is heavy weight Kinikea Pharmaceutical I'm betting someone will be interested if Maverick trial succeeds.
0 · Reply
ElieoG
ElieoG Mar. 19 at 10:12 PM
$CRDL that is the lowest closing price in close to 10 months if im not mistaking...with considerable volume .. whats next ..
2 · Reply
RobbyAxelrod1
RobbyAxelrod1 Mar. 19 at 7:15 PM
$CRDL Taking advantage of dip will see what happens.
1 · Reply
Rbyild
Rbyild Mar. 19 at 7:13 PM
$CRDL MMCAP on the dump again? If so, not good for a company that has been struggling for relevance getting anything to do with CBD adopted into western medicine after what 5 years? Can anyone say Vasogen 2! Bring on more of those 20k videos. 😂
0 · Reply
Covode13
Covode13 Mar. 19 at 6:50 PM
$CRDL wow new low for past 6 months. Ooo boy wonder how much worse it’s going to get!
1 · Reply
NancyPelosi____insider
NancyPelosi____insider Mar. 19 at 2:21 PM
$CRDL @Fastcapital when will this go up?
1 · Reply
Latest News on CRDL
Cardiol Therapeutics Announces Year-End 2024 Update on Operations

Tue, 01 Apr 2025 07:27:00 -0400 - 1 year ago

Cardiol Therapeutics Announces Year-End 2024 Update on Operations


Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index

Wed, 13 Nov 2024 08:00:00 -0500 - 1 year ago

Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index


Why Cardiol Therapeutics (CRDL) Stock Is Down 20% Today

2024-10-09T14:41:56.000Z - 1 year ago

Why Cardiol Therapeutics (CRDL) Stock Is Down 20% Today


Cardiol Therapeutics Announces Year-End 2023 Update on Operations

Tue, 02 Apr 2024 06:00:00 -0400 - 2 years ago

Cardiol Therapeutics Announces Year-End 2023 Update on Operations


Covode13
Covode13 Mar. 21 at 8:24 PM
$CRDL .80’s here we come.
0 · Reply
HeyYio
HeyYio Mar. 21 at 9:36 AM
$CRDL mmcap just got in bro. (The big investment I am referring to). I dont think 4 months have passed yet.
1 · Reply
Rbyild
Rbyild Mar. 20 at 7:01 PM
$CRDL I once heard Cramer say, “stocks stop going down at zero.” 😂 Pretty sure those at MMCAP know this. Currently a tute-bag-holder, that has a ton of shares and has dumped before. What sucks for retail is very few if any other tutes followed them down the rabbit hole this time. How bout them apples?
0 · Reply
Blueshadows
Blueshadows Mar. 20 at 5:58 PM
$CRDL well hopefully this doesn’t tank to much more. Like I said before I’m in till these trials are done just a personal choice and personal risk
1 · Reply
RobbyAxelrod1
RobbyAxelrod1 Mar. 20 at 5:43 PM
$CRDL Competitor is heavy weight Kinikea Pharmaceutical I'm betting someone will be interested if Maverick trial succeeds.
0 · Reply
ElieoG
ElieoG Mar. 19 at 10:12 PM
$CRDL that is the lowest closing price in close to 10 months if im not mistaking...with considerable volume .. whats next ..
2 · Reply
RobbyAxelrod1
RobbyAxelrod1 Mar. 19 at 7:15 PM
$CRDL Taking advantage of dip will see what happens.
1 · Reply
Rbyild
Rbyild Mar. 19 at 7:13 PM
$CRDL MMCAP on the dump again? If so, not good for a company that has been struggling for relevance getting anything to do with CBD adopted into western medicine after what 5 years? Can anyone say Vasogen 2! Bring on more of those 20k videos. 😂
0 · Reply
Covode13
Covode13 Mar. 19 at 6:50 PM
$CRDL wow new low for past 6 months. Ooo boy wonder how much worse it’s going to get!
1 · Reply
NancyPelosi____insider
NancyPelosi____insider Mar. 19 at 2:21 PM
$CRDL @Fastcapital when will this go up?
1 · Reply
Covode13
Covode13 Mar. 18 at 9:58 PM
$CRDL if this keeps going up And down. I’m going to swing trade this in my Roth hahah
1 · Reply
Covode13
Covode13 Mar. 18 at 5:17 PM
0 · Reply
NancyPelosi____insider
NancyPelosi____insider Mar. 18 at 1:50 PM
$CRDL this is really having a hard time breaking 1.10
1 · Reply
Nick_Ams
Nick_Ams Mar. 18 at 11:16 AM
$CRDL Fresh MAVERIC Phase 3 update on http://ClinicalTrials.gov (March 13). Recruitment is hitting full stride with top-tier sites active in US, EU, and Canada (Mayo, Cleveland Clinic, etc.). 50% enrollment milestone was hit in Jan, and the Sept 21, 2026 completion date remains firm. Execution is key! For those interested or who weren't aware yet. Check the record history here: https://clinicaltrials.gov/study/NCT06708299?tab=history
0 · Reply
moneytome
moneytome Mar. 17 at 12:36 PM
$CRDL about to break 1.1 and run soon
0 · Reply
Covode13
Covode13 Mar. 12 at 12:49 PM
0 · Reply
TheWinningStock
TheWinningStock Mar. 11 at 9:41 PM
$CRDL ....🤑
1 · Reply
ElieoG
ElieoG Mar. 11 at 2:28 PM
$CRDL good volume allready and breaking some 3 months resistance, possible breakout?
1 · Reply
VixTyler
VixTyler Mar. 11 at 5:59 AM
$CRDL Completion of enrollment is expected by the end of Q2 2026, setting the stage for a top-line data readout in the second half of 2026.
0 · Reply
zeke1019
zeke1019 Mar. 10 at 3:30 PM
$CRDL insiders are buying... Cardiol Therapeutics (CRDL) has experienced significant, consistent insider buying, primarily in late 2024 and October 2025, with no recorded sales in the last 3 years. Key executives, including CEO David Elsley and CFO Christopher Waddick, bought shares, signaling confidence following positive Phase 2 trial results.
1 · Reply
Covode13
Covode13 Mar. 10 at 12:08 PM
0 · Reply
Fastcapital
Fastcapital Mar. 9 at 5:06 PM
$CRDL https://finance.yahoo.com/news/cardiol-therapeutics-touts-phase-iii-230226821.html
0 · Reply